Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages

Shun He, Benjamin G. Chousterman, Ashley Fenn, Atsushi Anzai, Manfred Nairz, Martin Brandt, Ingo Hilgendorf, Yuan Sun, Yu Xiang Ye, Yoshiko Iwamoto, Benoit Tricot, Ralph Weissleder, Colin MacPhee, Peter Libby, Matthias Nahrendorf, Filip K. Swirski

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Healing after myocardial infarction (MI) involves the biphasic accumulation of inflammatory Ly-6Chigh and reparative Ly-6Clow monocytes/macrophages. Excessive inflammation disrupts the balance between the 2 phases, impairs infarct healing, and contributes to left ventricle remodeling and heart failure. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a member of the phospholipase A2 family of enzymes, produced predominantly by leukocytes, participates in host defenses and disease. Elevated Lp-PLA2 levels associate with increased risk of cardiovascular events across diverse patient populations, but the mechanisms by which the enzyme elicits its effects remain unclear. This study tested the role of Lp-PLA2 in healing after MI. Methods and Results-In response to MI, Lp-PLA2 levels markedly increased in the circulation. To test the functional importance of Lp-PLA2, we generated chimeric mice whose bone marrow-derived leukocytes were Lp-PLA2-deficient (bmLp-PLA2 -/-). Compared with wild-type controls, bmLp-PLA2 -/- mice subjected to MI had lower serum levels of inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, and decreased number of circulating inflammatory myeloid cells. Accordingly, bmLp-PLA2 -/- mice developed smaller and less inflamed infarcts with reduced numbers of infiltrating neutrophils and inflammatory Ly-6Chigh monocytes. During the later, reparative phase, infarcts of bmLp-PLA2 -/- mice contained Ly-6Clow macrophages with a skewed M2-prone gene expression signature, increased collagen deposition, fewer inflammatory cells, and improved indices of angiogenesis. Consequently, the hearts of bmLp-PLA2 -/- mice healed more efficiently, as determined by improved left ventricle remodeling and ejection fraction. Conclusions-Lp-PLA2 augments the inflammatory response after MI and antagonizes healing by disrupting the balance between inflammation and repair, providing a rationale for focused study of ventricular function and heart failure after targeting this enzyme acutely in MI.

Original languageEnglish
Pages (from-to)980-987
Number of pages8
JournalCirculation: Heart Failure
Volume8
Issue number5
DOIs
Publication statusPublished - 2015 Sep 1
Externally publishedYes

Fingerprint

1-Alkyl-2-acetylglycerophosphocholine Esterase
Macrophages
Myocardial Infarction
Leukocytes
Bone Marrow
Ventricular Remodeling
Monocytes
Enzymes
Heart Failure
Inflammation
Ventricular Function
Phospholipases A2
Myeloid Cells
Interleukin-1
Transcriptome
Interleukin-6

Keywords

  • Heart failure
  • inflammation
  • macrophages
  • monocytes
  • myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages. / He, Shun; Chousterman, Benjamin G.; Fenn, Ashley; Anzai, Atsushi; Nairz, Manfred; Brandt, Martin; Hilgendorf, Ingo; Sun, Yuan; Ye, Yu Xiang; Iwamoto, Yoshiko; Tricot, Benoit; Weissleder, Ralph; MacPhee, Colin; Libby, Peter; Nahrendorf, Matthias; Swirski, Filip K.

In: Circulation: Heart Failure, Vol. 8, No. 5, 01.09.2015, p. 980-987.

Research output: Contribution to journalArticle

He, S, Chousterman, BG, Fenn, A, Anzai, A, Nairz, M, Brandt, M, Hilgendorf, I, Sun, Y, Ye, YX, Iwamoto, Y, Tricot, B, Weissleder, R, MacPhee, C, Libby, P, Nahrendorf, M & Swirski, FK 2015, 'Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages', Circulation: Heart Failure, vol. 8, no. 5, pp. 980-987. https://doi.org/10.1161/CIRCHEARTFAILURE.115.002334
He, Shun ; Chousterman, Benjamin G. ; Fenn, Ashley ; Anzai, Atsushi ; Nairz, Manfred ; Brandt, Martin ; Hilgendorf, Ingo ; Sun, Yuan ; Ye, Yu Xiang ; Iwamoto, Yoshiko ; Tricot, Benoit ; Weissleder, Ralph ; MacPhee, Colin ; Libby, Peter ; Nahrendorf, Matthias ; Swirski, Filip K. / Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages. In: Circulation: Heart Failure. 2015 ; Vol. 8, No. 5. pp. 980-987.
@article{621970077b7d4a30965bcbd0924c5628,
title = "Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages",
abstract = "Healing after myocardial infarction (MI) involves the biphasic accumulation of inflammatory Ly-6Chigh and reparative Ly-6Clow monocytes/macrophages. Excessive inflammation disrupts the balance between the 2 phases, impairs infarct healing, and contributes to left ventricle remodeling and heart failure. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a member of the phospholipase A2 family of enzymes, produced predominantly by leukocytes, participates in host defenses and disease. Elevated Lp-PLA2 levels associate with increased risk of cardiovascular events across diverse patient populations, but the mechanisms by which the enzyme elicits its effects remain unclear. This study tested the role of Lp-PLA2 in healing after MI. Methods and Results-In response to MI, Lp-PLA2 levels markedly increased in the circulation. To test the functional importance of Lp-PLA2, we generated chimeric mice whose bone marrow-derived leukocytes were Lp-PLA2-deficient (bmLp-PLA2 -/-). Compared with wild-type controls, bmLp-PLA2 -/- mice subjected to MI had lower serum levels of inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, and decreased number of circulating inflammatory myeloid cells. Accordingly, bmLp-PLA2 -/- mice developed smaller and less inflamed infarcts with reduced numbers of infiltrating neutrophils and inflammatory Ly-6Chigh monocytes. During the later, reparative phase, infarcts of bmLp-PLA2 -/- mice contained Ly-6Clow macrophages with a skewed M2-prone gene expression signature, increased collagen deposition, fewer inflammatory cells, and improved indices of angiogenesis. Consequently, the hearts of bmLp-PLA2 -/- mice healed more efficiently, as determined by improved left ventricle remodeling and ejection fraction. Conclusions-Lp-PLA2 augments the inflammatory response after MI and antagonizes healing by disrupting the balance between inflammation and repair, providing a rationale for focused study of ventricular function and heart failure after targeting this enzyme acutely in MI.",
keywords = "Heart failure, inflammation, macrophages, monocytes, myocardial infarction",
author = "Shun He and Chousterman, {Benjamin G.} and Ashley Fenn and Atsushi Anzai and Manfred Nairz and Martin Brandt and Ingo Hilgendorf and Yuan Sun and Ye, {Yu Xiang} and Yoshiko Iwamoto and Benoit Tricot and Ralph Weissleder and Colin MacPhee and Peter Libby and Matthias Nahrendorf and Swirski, {Filip K.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.115.002334",
language = "English",
volume = "8",
pages = "980--987",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Lp-PLA2 Antagonizes Left Ventricular Healing after Myocardial Infarction by Impairing the Appearance of Reparative Macrophages

AU - He, Shun

AU - Chousterman, Benjamin G.

AU - Fenn, Ashley

AU - Anzai, Atsushi

AU - Nairz, Manfred

AU - Brandt, Martin

AU - Hilgendorf, Ingo

AU - Sun, Yuan

AU - Ye, Yu Xiang

AU - Iwamoto, Yoshiko

AU - Tricot, Benoit

AU - Weissleder, Ralph

AU - MacPhee, Colin

AU - Libby, Peter

AU - Nahrendorf, Matthias

AU - Swirski, Filip K.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Healing after myocardial infarction (MI) involves the biphasic accumulation of inflammatory Ly-6Chigh and reparative Ly-6Clow monocytes/macrophages. Excessive inflammation disrupts the balance between the 2 phases, impairs infarct healing, and contributes to left ventricle remodeling and heart failure. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a member of the phospholipase A2 family of enzymes, produced predominantly by leukocytes, participates in host defenses and disease. Elevated Lp-PLA2 levels associate with increased risk of cardiovascular events across diverse patient populations, but the mechanisms by which the enzyme elicits its effects remain unclear. This study tested the role of Lp-PLA2 in healing after MI. Methods and Results-In response to MI, Lp-PLA2 levels markedly increased in the circulation. To test the functional importance of Lp-PLA2, we generated chimeric mice whose bone marrow-derived leukocytes were Lp-PLA2-deficient (bmLp-PLA2 -/-). Compared with wild-type controls, bmLp-PLA2 -/- mice subjected to MI had lower serum levels of inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, and decreased number of circulating inflammatory myeloid cells. Accordingly, bmLp-PLA2 -/- mice developed smaller and less inflamed infarcts with reduced numbers of infiltrating neutrophils and inflammatory Ly-6Chigh monocytes. During the later, reparative phase, infarcts of bmLp-PLA2 -/- mice contained Ly-6Clow macrophages with a skewed M2-prone gene expression signature, increased collagen deposition, fewer inflammatory cells, and improved indices of angiogenesis. Consequently, the hearts of bmLp-PLA2 -/- mice healed more efficiently, as determined by improved left ventricle remodeling and ejection fraction. Conclusions-Lp-PLA2 augments the inflammatory response after MI and antagonizes healing by disrupting the balance between inflammation and repair, providing a rationale for focused study of ventricular function and heart failure after targeting this enzyme acutely in MI.

AB - Healing after myocardial infarction (MI) involves the biphasic accumulation of inflammatory Ly-6Chigh and reparative Ly-6Clow monocytes/macrophages. Excessive inflammation disrupts the balance between the 2 phases, impairs infarct healing, and contributes to left ventricle remodeling and heart failure. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a member of the phospholipase A2 family of enzymes, produced predominantly by leukocytes, participates in host defenses and disease. Elevated Lp-PLA2 levels associate with increased risk of cardiovascular events across diverse patient populations, but the mechanisms by which the enzyme elicits its effects remain unclear. This study tested the role of Lp-PLA2 in healing after MI. Methods and Results-In response to MI, Lp-PLA2 levels markedly increased in the circulation. To test the functional importance of Lp-PLA2, we generated chimeric mice whose bone marrow-derived leukocytes were Lp-PLA2-deficient (bmLp-PLA2 -/-). Compared with wild-type controls, bmLp-PLA2 -/- mice subjected to MI had lower serum levels of inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, and decreased number of circulating inflammatory myeloid cells. Accordingly, bmLp-PLA2 -/- mice developed smaller and less inflamed infarcts with reduced numbers of infiltrating neutrophils and inflammatory Ly-6Chigh monocytes. During the later, reparative phase, infarcts of bmLp-PLA2 -/- mice contained Ly-6Clow macrophages with a skewed M2-prone gene expression signature, increased collagen deposition, fewer inflammatory cells, and improved indices of angiogenesis. Consequently, the hearts of bmLp-PLA2 -/- mice healed more efficiently, as determined by improved left ventricle remodeling and ejection fraction. Conclusions-Lp-PLA2 augments the inflammatory response after MI and antagonizes healing by disrupting the balance between inflammation and repair, providing a rationale for focused study of ventricular function and heart failure after targeting this enzyme acutely in MI.

KW - Heart failure

KW - inflammation

KW - macrophages

KW - monocytes

KW - myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84957616560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957616560&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.115.002334

DO - 10.1161/CIRCHEARTFAILURE.115.002334

M3 - Article

VL - 8

SP - 980

EP - 987

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 5

ER -